Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainEGF_1

NTN5 SSPOP

1.31e-02255132PS00022
DomainEGF_2

NTN5 SSPOP

1.41e-02265132PS01186
Pubmed

Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.

PER1 TTC39A

1.96e-04561329455484
Cytoband7q36.1

SSPOP ZNF775

1.98e-04741327q36.1
CytobandEnsembl 112 genes in cytogenetic band chr7q36

SSPOP ZNF775

9.07e-04159132chr7q36
CytobandEnsembl 112 genes in cytogenetic band chr17p13

PER1 BHLHA9

4.18e-03346132chr17p13
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NTN5 HRG PEAK3

8.97e-06144133cf9f049ab6cd80521598124f057c2debdde24788
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NTN5 HRG PEAK3

8.97e-0614413341eaeca54b3c39de417597267cbdb1f195dd885a
ToppCellHippocampus|World / BrainAtlas - Mouse McCarroll V32

NTN5 BHLHA9 ZNF575

1.64e-05176133f120a703f6d2f2d5f55eae1aea2e6382a485828f
ComputationalGenes in the cancer module 41.

PER1 PIGQ HRG

5.58e-0456643MODULE_41
DrugVincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A

PER1 PIGQ TTC39A

1.61e-041931334341_UP
Drug2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A

PER1 C2orf68 TTC39A

1.71e-041971331222_DN
DrugBendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A

PER1 HRG TTC39A

1.71e-041971334315_UP
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A

PER1 PIGQ C2orf68

1.74e-041981332845_UP
DrugDemeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A

PER1 PIGQ TTC39A

1.74e-041981333706_DN
DrugBenzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A

PER1 PIGQ TTC39A

1.76e-041991334140_UP
DrugLevamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A

PER1 PIGQ C2orf68

1.76e-041991332257_DN
DrugSTOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A

PER1 PIGQ TTC39A

1.76e-041991336869_UP
DrugEserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A

PER1 PIGQ HRG

1.76e-041991335749_UP
DrugCalycanthine [595-05-1]; Up 200; 11.6uM; PC3; HT_HG-U133A

PER1 HRG TTC39A

1.79e-042001335744_UP
Diseasereticulocyte measurement

PER1 PIGQ PLEKHA7

7.83e-031053123EFO_0010700
Diseaseage at menarche

NTN5 PLEKHA7

2.34e-02594122EFO_0004703

Protein segments in the cluster

PeptideGeneStartEntry
APRGPCGHLECHGPA

BHLHA9

126

Q7RTU4
HPRPGHCCKPGGRLD

C2orf68

6

Q2NKX9
PHNQGHCCHGHGPPP

HRG

421

P04196
HCCHGHGPPPGHLRR

HRG

426

P04196
GCHHGPAPPSRRHHC

PER1

821

O15534
RLMGGHPGPCHPGHS

PEAK3

156

Q6ZS72
GVGGGHSPMCPPHCH

MYO15B

6

Q96JP2
GGPCAPHHAPCARGP

SSPOP

1601

A2VEC9
PHHAPCARGPHCVSP

SSPOP

1606

A2VEC9
RPPRCHCRHHTTGPG

NTN5

171

Q8WTR8
CGHHGGEHSNPRCPE

PIGQ

646

Q9BRB3
VGPGHTRDCPHRGHD

PLEKHA7

316

Q6IQ23
HRLAHGGARPHPCPD

ZNF575

81

Q86XF7
LTHSGARPHPCPHCP

ZNF575

111

Q86XF7
HTGERPHPCPHCGRG

ZNF775

331

Q96BV0
HDPSHACSCPPGPGR

TTC39A

156

Q5SRH9